Literature DB >> 27921431

[Short-term and long-term glycemic variability and its relationship to microvascular complications of diabetes].

Martin Prázný, Jan Škrha, Jan Šoupal, Jan Škrha.   

Abstract

Vascular complications of diabetes result from long lasting unsatisfactory glycemic control. We usually assess glycemic control based on the value of glycated hemoglobin HbA1c. The glycated hemoglobin test, however, says nothing about short-term glycemic fluctuations. Recently, continuous monitoring of glycemia has enabled us an in-depth assessment of changes in glucose concentrations, called glycemic variability. In connection with the research into short-term glycemic variability, also the study of long-term fluctuations in glycemic control based on HbA1c variability has now intensified. Glycemic variability may be related to oxidation stress, endothelial dysfunction and inflammation, the factors traditionally associated with vascular damage. Several studies have described the relation of glycemic variability to macrovascular complications of diabetes, still its relation to microvascular complications remains unclear. This overview summarizes the recent findings in the field of glycemic variability and its possible association with retinopathy, nephropathy and neuropathy.Key words: type 1 and 2 diabetes mellitus - glycemic variability - microvascular complications - HbA1c - variability.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27921431

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  2 in total

1.  Calculating the Mean Amplitude of Glycemic Excursions from Continuous Glucose Data Using an Open-Code Programmable Algorithm Based on the Integer Nonlinear Method.

Authors:  Xuefei Yu; Liangzhuo Lin; Jie Shen; Zhi Chen; Jun Jian; Bin Li; Sherman Xuegang Xin
Journal:  Comput Math Methods Med       Date:  2018-03-08       Impact factor: 2.238

2.  Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial.

Authors:  Lu Yuan; Fengfei Li; Yue Zhou; Rui Sun; Gu Gao; Qing Zhang; Yajuan Tang; Lu Dai; Jindan Wu; Jianhua Ma
Journal:  J Diabetes Res       Date:  2021-07-14       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.